We were the first to prepare and characterize unnatural (+)-naloxone (1978) and (+)-naltrexone (1997) as opioid receptor inert research tools useful for detecting opioid receptor mediated effects when used in conjunction with (-)-naloxone and (-)-naltrexone, both high affinity clinical useful narcotic antagonists. We know now that (+)-naloxone and (+)-naltrexone, long thought to be inert compounds, are functional antagonists of Toll-like 4 (TLR-4) receptors and that selective acute functional antagonism of TLR-4 by (+)-naloxone and (+)-naltrexone results in reversal of neuropathic pain as well as potentiation of opioid analgesia. Earlier we introduced the concept of toll-like receptor mediated glial activation as central to all of the following: neuropathic pain, compromised acute opioid analgesia, and unwanted opioid side effects (tolerance, dependence, and reward). Attenuation of glial activation was demonstrated both to alleviate exaggerated pain states induced by experimental pain models and to reduce the development of opioid tolerance. We have now extended our studies of TLR4 antagonism to the physiological process of birth (parturition). Prior work had shown that an inflammatory response is instrumental in parturition but the upstream signals initiating inflammation have not been defined. Endogenous ligands for TLR4 receptors are released in late gestation, so we examined the possibility that on-time labor requires TLR4 signaling to trigger a cytokine and leukocyte response and accelerate the parturition cascade. We found that (+)-naltrexone-induced TLR4 antagonism increased the mean gestation period in wild type mice by 16 hours vs normal controls. These and other data including that from TLR4 deficient mice demonstrate that TLR4 is a key upstream regulator of the inflammatory response acting to drive uterine activation and control the timing of labor. Since causal pathways for term and preterm labor converge with TLR4, interventions to manipulate TLR4 signaling may have therapeutic utility for women at risk of preterm labor, or in post-term pregnancy.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2015
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
Zip Code
Jacobsen, Jonathan Henry W; Buisman-Pijlman, Femke T; Mustafa, Sanam et al. (2018) Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood. Neuropharmacology 128:460-473
Anttila, Jenni E; Albert, Katrina; Wires, Emily S et al. (2018) Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury. eNeuro 5:
Jacobsen, Jonathan Henry W; Buisman-Pijlman, Femke T A; Mustafa, Sanam et al. (2018) The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle. Brain Behav Immun 67:181-193
Zhang, Xiaozheng; Cui, Fengchao; Chen, Hongqian et al. (2018) Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists. J Chem Inf Model 58:816-825
Grace, Peter M; Strand, Keith A; Galer, Erika L et al. (2018) Protraction of neuropathic pain by morphine is mediated by spinal damage associated molecular patterns (DAMPs) in male rats. Brain Behav Immun 72:45-50
Wieseler, Julie; Ellis, Amanda; McFadden, Andrew et al. (2017) Supradural inflammatory soup in awake and freely moving rats induces facial allodynia that is blocked by putative immune modulators. Brain Res 1664:87-94
Grace, Peter M; Strand, Keith A; Galer, Erika L et al. (2016) Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation. Proc Natl Acad Sci U S A 113:E3441-50
Ellis, Amanda; Grace, Peter M; Wieseler, Julie et al. (2016) Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury. Brain Behav Immun 58:348-356
Chin, Peck Yin; Dorian, Camilla L; Hutchinson, Mark R et al. (2016) Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth. Sci Rep 6:36112
Wang, X; Zhang, Y; Peng, Y et al. (2016) Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br J Pharmacol 173:856-69

Showing the most recent 10 out of 29 publications